Case reportInitial experience using propranolol as the sole treatment for infantile airway hemangiomas
Introduction
Infantile hemangiomas are the most common pediatric tumor occurring in approximately 1–2% of newborns, with a much higher rate in premature infants [1]. The natural course has been well documented with most becoming apparent within the first 2 months of life, undergoing a proliferative phase in the first year of life, and slowly involuting over the early childhood years. Frequently infantile hemangiomas involve the head and neck region and have a significant cosmetic component. More serious lesions involving the airway and orbit necessitate early intervention to avoid airway compromise and vision abnormalities.
Medical treatment of infantile airway hemangiomas has centered upon intralesional and oral steroids with interferon and vincristine being reserved for life threatening lesions [2]. Surgical treatment has included tracheotomy, laser excision, and open airway excision [3]. None of these treatments are without significant side effects. Long-term corticosteroid administration can result in growth suppression and other developmental and metabolic derangements. Furthermore, steroid treatment alone will result in the need for a tracheotomy in over one-third of patients [2]. Infant tracheotomy has a well documented morbidity rate, laser excisions pose a significant risk for airway scarring, and open airway procedures require experienced surgeons with highly skilled intensivist post operative care [4], [5], [6].
Propranolol has recently been introduced as a treatment for infantile hemangiomas [7], [8], [9], [10], [11]. Initial case reports have demonstrated rapid response to oral propranolol in both skin and airway hemangiomas after primary medical and surgical treatment were unsuccessful [7], [8], [9], [10], [11]. No report though has specifically identified using propranolol as the initial and only treatment for airway hemangioma. In this paper we describe infantile hemangiomas involving the supraglottic and subglottic airway that were all treated solely with propranolol.
Section snippets
Case 1
A 3-month old, otherwise healthy infant female, presented with gradual onset of inspiratory stridor over a 2-week period. There were no feeding difficulties and no apneic or cyanotic episodes. Skin exam did not reveal any lesions and head and neck exam was normal except for a flexible nasopharyngoscopy which revealed a supraglottic mass suspicious for a hemangioma. Imaging to include an MRI of the neck revealed an isolated paraglottic mass consistent with a hemangioma. Ultrasound of the brain
Literature review
Propranolol treatment for infantile hemangiomas has only recently been described [7], [8], [9], [10], [11]. Initial success was found fortuitously when a nasal hemangioma was noticed to decrease in size after propranolol treatment was started for obstructive cardiomyopathy [7]. Since this time there have been case reports describing successful treatment of infantile hemangiomas with propranolol as an adjuvant medication after other medical and surgical treatments have failed; successful
Conclusion
There is a growing literature base that demonstrates the effectiveness of propranolol as a treatment for head and neck infantile hemangiomas. Initial success along with a low side effect profile is an exciting breakthrough for the treatment especially of infantile airway hemangiomas where many children suffer the untoward side effects of corticosteroids and the complications inherent in tracheotomy and multiple laser procedures. Airway hemangiomas are relatively rare so long-term prospective
Conflict of interest statement
Authors report no financial conflicts of interest relative to this article. There was no external funding associated with this report.
References (11)
- et al.
Pediatric head and neck lesions
Pediatr. Clin. N. Am.
(1998) - et al.
Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals
Int. J. Pediatr. Obesity
(2009) - et al.
Pediatric tracheotomies: a 37 year experience in 282 children
Int. J. Pediatr. Obesity
(2009) - et al.
Pediatric tracheotomy: 17 year review
Int. J. Pediatr. Obesity
(2007) - et al.
Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
Int. J. Pediatr. Obesity
(2009)
Cited by (65)
Management of Infantile Hemangiomas of the Airway
2018, Otolaryngologic Clinics of North AmericaCitation Excerpt :The efficacy of propranolol in treating cutaneous IH is now well established in systematic reviews and meta-analyses of clinical reports,37,38 large cohort studies,39 and randomized clinical trials.40,41 Propranolol has also been used successfully in the management of airway IHs.42–56 Response is not universal, however, and symptoms may recur while on the medication or during weaning, with reported symptom recurrence rates as high as 50%.52–54,57,58
Imaging in Otolaryngology
2018, Imaging in OtolaryngologyDiagnostic Imaging: Head and Neck
2017, Diagnostic Imaging: Head and NeckDiagnostic Imaging: Pediatrics
2017, Diagnostic Imaging: PediatricsUse of intravenous propranolol for control of a large cervicofacial hemangioma in a critically ill neonate
2016, International Journal of Pediatric OtorhinolaryngologyIntra-thyroidal hemangioma-A rare congenital anomaly: Case presentation and literature review
2014, International Journal of Pediatric Otorhinolaryngology
- 1
Tel.: +1 617 573 4206.